Islet Autoantibodies

Diabetes & Endocrinology news Public Health

New International Consensus: Screening the General Population for Islet Autoantibodies to Detect Early-Stage Type 1 Diabetes

By MedXY 09/13/2026

An international expert consensus recommends practical principles and minimum requirements for general‑population screening for islet autoantibodies to detect early-stage type 1 diabetes, reduce DKA, enable early care and access to disease‑modifying therapies.

Diabetes & Endocrinology news Public Health

Racial, Ethnic, and Socioeconomic Disparities in Islet Autoantibody Patterns Among Individuals at Risk for Type 1 Diabetes

By MedXY 08/24/2026

Islet autoantibody positivity varies significantly among racial and ethnic groups and is influenced by socioeconomic deprivation, implicating tailored screening and prevention strategies for equitable diabetes care.

Diabetes & Endocrinology news Pediatrics

Deciphering ZnT8A: Why Not All Islet Autoantibodies Predict Type 1 Diabetes Risk

By MedXY 03/07/2026

The ENDIA cohort study reveals that persistent single ZnT8 autoantibodies detected only via ELISA after age 4 do not significantly increase Type 1 Diabetes risk, whereas earlier detection across multiple assay formats signals higher progression probability.